Preparation and in vitro characterization of gellan based floating beads of acetohydroxamic acid for eradication of H. pylori
Gellan based floating beads of acetohydroxamic acid (AHA) were prepared by the ionotropic gellation method to achieve controlled and sustained drug release for treatment of Helicobacter pylori infection. The prepared beads were evaluated for diameter, surface morphology and encapsulation efficiency. Formulation parameters like concentrations of gellan, chitosan, calcium carbonate and the drug influenced the in vitro drug release characteristics of beads. Drug and polymer interaction studies were carried out using differential scanning calorimetry. Chitosan coating increased encapsulation efficiency of the beads and reduced the initial burst release of the drug from the beads. Kinetic treatment of the drug release data revealed a matrix diffusion mechanism. Prepared floating beads showed good antimicrobial activity (in vitro H. pylori culture) as potent urease inhibitors. In conclusion, an oral dosage form of floating gellan beads containing AHA may form a useful stomach site specific drug delivery system for the treatment of H. pylori infection.
A. Rubinstein and D. R. Friend, Site-specific Delivery to the Gastrointestinal Tract, in Polymeric Site-Specific Pharmacotherapy (Ed. A. J. Domb), Wiley, Chichester 1994, pp. 267-313.
N. Nagahara, Y. Akiyama, M. Tada, M. Nakao, M. Kitano and Y. Ogawa, Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori, Antimicrob. Agents Chemother.42 (1998) 2492-2494.
R. Hejazi and M. Amiji, Stomach-specific anti-H. pylori therapy. I. Preparation and characterization of tetracycline-loaded chitosan microspheres, Int. J. Pharm.235 (2002) 87-94; DOI: 10. 1016/S0378-5173(01)00985-1.
R. B. Umamaheshwari, S. Jain and N. K. Jain, A new approach in gastroretentive drug delivery system using cholestyramine, Drug Deliv.10 (2003) 151-160; DOI: 10.1080/713840399.
B. J. Marshall and J. R. Warren, Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration, Lancet1 (1984) 1311-1315; DOI: 10.1016/S0140-6736(84)91816-6.
P. S. Rajinikanth, J. Balasubramanium and B. Mishra, Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradicating of Helicobacter pylori, Int. J. Pharm.335 (2007) 114-122; DOI: 10.1016/j.ijpharm.2006.11.009.
C. K. Lin, P. I. Hsu and K. H. Lai, One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy, J. Clin. Gastroenterol.34 (2002) 547-551.
R. B. Umamaheshwari, R. Suman and N. K. Jain, Anti Helicobacter pylori effect of mucoadhesive nanoparticle bearing amoxicillin in experimental gerbils, APPS Pharm. Sci. Tech.5 (2004) article 32.
A. M. El. Nujumi, C. A. Dorrian, R. S. Chittajallu, W. D. Neithercut, K. E. L. McColl, Effect of inhibition of Helicobacter pylori urease activity of acetohydroxamic acid on serum gastrin in duodenal ulcer subjects, Gut32 (1991) 866-870.
H. L. Mobley, L. T. Hu and P. Foxall, Helicobacter pylori urease: Properties and role in pathogenesis, Scand. J. Gastroenterol. Suppl.187 (1991) 39-46.
S. H. Phadnis, M. H. Parlow, M. Levy, D. Iher, C. M. Canldine, J. B. Connors and B. E. Dunn, Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis, Infect. Immun.64 (1996) 905-912.
S. Miyazaki, N. Kawasaki, W. Kudo and D. Attwood, Comparison of in situ gelling formulation for oral delivery of cimetidine, Int. J. Pharm.220 (2001) 161-168; DOI: 10.1016/S0378-5173(01) 00669-X.
United State Pharmacopeia 24 /National Formulary 19, USP Convention, Rockville, MD, 2002.
S. A. Agnihotri, S. S. Jawalkar and T. M. Aminabhavi, Controlled release of cephalexin through gellan gum beads: Effect of formulation parameters on entrapment efficiency, size, and drug release, Eur. J. Pharm. Biopharm.63 (2006) 249-261; DOI: 10.1016/j.ejpb.2005.12.008.
I. Corthesy-Theulaz, N. Portal, M. Glauser, E. Saraga, R. Haas, J. P. Kraehenbushl, A. L. Blem and P. Michetti, Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice, Gastroenterology109 (1995) 115-121; DOI: 10.1016/0016-5085(95)90275-9.
H. Grasdalen and O. Smidsroed, Gellation of gellan gum, Carbohyd. Polym.7 (1987) 371-393; DOI: 10.1016/0144-8617(87)90004-X.
R. Chandrasekaran, L. C. Puigianer, K. L. Joyce and S. Arnotts, The influence of calcium ions, acetate and L-glycerate groups on the gellan double-helix, Carbohyd. Res.181 (1988) 23-40; DOI: 10.1016/0008-6215(88) 84020-5.
R. Chandrasekaran and V. G. Thailambad, Cation interactions in gellan: An x-ray study of the potassium salt, Carbohyd. Polym.12 (1990) 431-442; DOI: 10.1016/0144-8617(90)90092-7.
A. D. Sezer and J. Akbuga, Release characteristics of chitosan treated alginate beads. I. Sustained release of low molecular drug from chitosan treated alginate beads, J. Microencapsul.16 (1999) 195-203; DOI: 10.1080/026520499288636.
P. S. Rajinikanth, C. Sankar and B. Mishra, Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation, Drug Deliv.10 (2003) 21-28; DOI: 10.1080/713840323.
J. Balasubramaniam and J. K. Pandit, Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride, Drug Deliv.10 (2003) 185-191; DOI: 10.1080/713840402.
W. I. Higuchi, Analysis of data on the medicament release from ointments, J. Pharm. Sci.51 (1962) 802-804.
R. W. Korsmeyer, R. Gurney, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm.15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.